Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis
Reproduction · 2026
DOI: 10.1093/reprod/xaaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, 2026. Verfasst von Jiayu Lin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China. Hauptthemen laut MEDLINE: Endometriosis, HSP90 Heat-Shock Proteins, Lactams, Macrocyclic, Benzoquinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Longgang District Science and Technology Innovation Special Foundation.
Abstract (Originalsprache)
Endometriosis, a chronic inflammatory condition characterized by pain and infertility, remains a clinical challenge. Current hormonal and surgical treatments are often limited by side effects and high recurrence rates. In search of more effective and less invasive alternatives, we analyzed a single-cell RNA sequencing dataset of menstrual effluents from patients (GSE203191) and identified a significant upregulation of heat shock protein 90 (HSP90), suggesting its pathogenic involvement. Using primary endometrial stromal cells (ESCs) isolated from human ovarian endometrioma and a murine endometriosis model, we evaluated the therapeutic potential of HSP90 inhibition with 17-allylamino-17-demethoxygeldanamycin (17-AAG). In vitro, 17-AAG (10 nM–10 μM) reduced ESC viability and proliferation in a dose-dependent manner while increasing caspase-3 activity. In vivo, 17-AAG (30 μg/g) significantly attenuated ectopic lesion growth without impairing systemic parameters such as body weight, anti-Müllerian hormone, or estrogen levels. Proteomic profiling revealed disruption of HSP90 client networks, including downregulation of importin 4 and tubulin gamma complex protein 3, and upregulation of DnaJ heat shock protein family member B1, glutamate-ammonia ligase, and sequestosome 1. These findings highlight HSP90 as a promising non-hormonal therapeutic target in endometriosis, offering mechanistic insights and translational potential for more targeted, well-tolerated treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- Department of Obstetrics and Gynaecology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong S.A.R, 999077, China.
- Shenzhen Key Laboratory of Fertility Regulation, Reproductive Medicine Center, the University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, 518053, China.
- Guangdong Engineering Technology Research Center of Fertility Preservation, Guangzhou, Guangdong, 510799, China.
- Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Jingjie Li
Förderung
- National Natural Science Foundation of China
- Shenzhen Longgang District Science and Technology Innovation Special Foundation
Zitieren
APA
Lin, J., Zhao, W., Li, M., Liu, M., Guo, Q., Wu, T., Xiang, Y., Liu, J., Zeng, Y., Liang, Q., Liang, X., Zhou, C., & Li, J. (2026). Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis. Reproduction. https://doi.org/10.1093/reprod/xaaf002
Vancouver
Lin J, Zhao W, Li M, Liu M, Guo Q, Wu T, et al. Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis. Reproduction. 2026. doi:10.1093/reprod/xaaf002
BibTeX
@article{Lin2026,
author = {Lin, Jiayu and Zhao, Weie and Li, Manchao and Liu, Mingxin and Guo, Qi and Wu, Taibao and Xiang, Yuting and Liu, Jiawen and Zeng, Yanyan and Liang, Qiqi and Liang, Xiaoyan and Zhou, Chuanchuan and Li, Jingjie},
title = {Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis},
journal = {Reproduction},
year = {2026},
doi = {10.1093/reprod/xaaf002}
}
EUVIMED